Jun Mochizuki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jun Mochizuki has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Koji Nagashima
TechnoSuruga Laboratory Co., Ltd., Shizuoka 424-0065, Japan
2 shared publications - Haerani Rasyid
Department of Internal Medicine, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
1 shared publication - Hiroyuki Yamamoto
Department of Health and Nutritional Sciences, Faculty of Food and Health Sciences, Aichi Shukutoku University, Aichi, Japan
1 shared publication Katsuhiko Fukuda
1 shared publication- Kazuaki Iguchi
Laboratory of Bioorganic Chemistry, School of Pharmaceutical Sciences, University of Shizuoka
1 shared publication - Keiko Unno
Tea Science Center, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan
1 shared publication
Latest Publications
- Open Access
- 15 July 2025
- Published by IntechOpen
A New Dietary Therapy with Low Protein Processed Genmai (Brown Rice) for CKD by Correcting Gut-Kidney Axis
The number of chronic kidney disease (CKD) patients continues to increase globally, according to the increases in obesity, diabetes mellitus, hypertension, and aged people. When the glomerular lesions progress, it can lead to end-stage renal disease, which requires hemodialysis or transplantation. It is historically proven that a low-protein diet is effective for the palliative treatment of uremia. Current drug therapy targeting kidney lesions is insufficient, while dietary therapy is rather ignorant. We developed a low-protein processed genmai (brown rice) (LPPG) to improve CKD management. The essential functional features of brown rice are retained in LPPG and ameliorate the negative spiral of gut-kidney linkage caused by uremic dysbiosis and a leaky gut. LPPG is characterized by an energy value the same as white rice, a protein content of less than 0.2 g/100 g boiled rice, a potassium content that is almost zero, phosphorus of less than a quarter that of conventional rice, the presence of dietary fiber, γ-oryzanol, and antioxidant activity. We tried to clarify the functional mechanism to decrease uremic toxins by improvement of dysbiosis of the colonic microbiota, changes in short-chain fatty acids, and decreased uremic toxins and inflammatory biomarkers through pro- and post-intervention clinical trials in Japan, China, and Indonesia. Changes in microbiota were essential, with increased Firmicutes and decreased Proteobacteria at the phylum level, and Blautia played the essential role for gut microbiota reconstruction at the genus level. We propose a new personalized therapy with LPPG for all stages of CKD patients by decreasing uremic toxins and hidden inflammation.
- 15 July 2025
- Published by IntechOpen
Open AccessA New Dietary Therapy with Low Protein Processed Genmai (Brown Rice) for CKD by Correcting Gut-Kidney Axis
The number of chronic kidney disease (CKD) patients continues to increase globally, according to the increases in obesity, diabetes mellitus, hypertension, and aged people. When the glomerular lesions progress, it can lead to end-stage renal disease, which requires hemodialysis or transplantation. It is historically proven that a low-protein diet is effective for the palliative treatment of uremia. Current drug therapy targeting kidney lesions is insufficient, while dietary therapy is rather ignorant. We developed a low-protein processed genmai (brown rice) (LPPG) to improve CKD management. The essential functional features of brown rice are retained in LPPG and ameliorate the negative spiral of gut-kidney linkage caused by uremic dysbiosis and a leaky gut. LPPG is characterized by an energy value the same as white rice, a protein content of less than 0.2 g/100 g boiled rice, a potassium content that is almost zero, phosphorus of less than a quarter that of conventional rice, the presence of dietary fiber, γ-oryzanol, and antioxidant activity. We tried to clarify the functional mechanism to decrease uremic toxins by improvement of dysbiosis of the colonic microbiota, changes in short-chain fatty acids, and decreased uremic toxins and inflammatory biomarkers through pro- and post-intervention clinical trials in Japan, China, and Indonesia. Changes in microbiota were essential, with increased Firmicutes and decreased Proteobacteria at the phylum level, and Blautia played the essential role for gut microbiota reconstruction at the genus level. We propose a new personalized therapy with LPPG for all stages of CKD patients by decreasing uremic toxins and hidden inflammation.
- Open Access
Beneficial Effects of Enoki Mushroom Extract on Male Menopausal Symptoms in Japanese Subjects: A Randomized, Double-Blind, Placebo-Controlled Study
With the increase in average life expectancy, age-related male menopause has become a cause of decreased quality of life in men. The present study investigated the efficacy and safety of powdered enoki mushroom extract containing adenosine (test food) for menopausal symptoms in middle-aged and elderly men based on an evaluation of Heinemann’s Aging Males’ Symptoms (AMS) scores. The test food and placebo were administered to healthy men with AMS scores of 27–49 for 12 weeks. AMS score (primary endpoint) and testosterone level (secondary endpoint) were evaluated before and 12 weeks after the intake of the test food and placebo. The intake of the test food for 12 weeks significantly improved the sexual subscale of the AMS. In the cumulative χ2 test, the number of subjects showing high improvement was significantly higher in the test food group than in the placebo food group. In a stratified analysis of subjects divided into two groups based on a change in total testosterone levels of <0.5 ng/mL and ≥0.5 ng/mL after the intake of the test food, the number of subjects with increased total testosterone levels of ≥0.5 ng/mL was significantly higher in the test food group than in the placebo group. These results suggest the beneficial effects of enoki mushroom extract on symptoms of male menopause.
Open AccessBeneficial Effects of Enoki Mushroom Extract on Male Menopausal Symptoms in Japanese Subjects: A Randomized, Double-Blind, Placebo-Controlled Study
With the increase in average life expectancy, age-related male menopause has become a cause of decreased quality of life in men. The present study investigated the efficacy and safety of powdered enoki mushroom extract containing adenosine (test food) for menopausal symptoms in middle-aged and elderly men based on an evaluation of Heinemann’s Aging Males’ Symptoms (AMS) scores. The test food and placebo were administered to healthy men with AMS scores of 27–49 for 12 weeks. AMS score (primary endpoint) and testosterone level (secondary endpoint) were evaluated before and 12 weeks after the intake of the test food and placebo. The intake of the test food for 12 weeks significantly improved the sexual subscale of the AMS. In the cumulative χ2 test, the number of subjects showing high improvement was significantly higher in the test food group than in the placebo food group. In a stratified analysis of subjects divided into two groups based on a change in total testosterone levels of <0.5 ng/mL and ≥0.5 ng/mL after the intake of the test food, the number of subjects with increased total testosterone levels of ≥0.5 ng/mL was significantly higher in the test food group than in the placebo group. These results suggest the beneficial effects of enoki mushroom extract on symptoms of male menopause.
- Open Access
Enokitake Mushroom and Its Active Component, Adenosine, Which Restores Testosterone Production in Impaired and Fatigued Mouse Models
Several studies have reported the effects of the consumption of various mushroom species on the testes in animal experimental models. Mushrooms, including enokitake mushrooms (Flammulina velutipes), and vegetables contain adenosine may affect testosterone production. Here, we aimed to elucidate the effects of enokitake and its active component, adenosine, on testosterone production in primary cultures of testicular cells in vivo using mice models and in vitro. The administration of enokitake ethanolic extract increased testosterone production in the cisplatin-impaired mouse model. The direct effect of mushroom extracts on testicular cells was examined and liquid chromatography–mass spectrometry analysis confirmed that the mushroom- and vegetable-induced increase in testosterone production mainly involved adenosine. Additionally, the administration of enokitake extract or adenosine to wet floor fatigue model mice promoted testicular testosterone production and enhanced Leydig cell function through insulin-like peptide three level upregulation. Structurally related compounds, including cordycepin, showed lower bioactivity than adenosine. This study showed that the ingestion of adenosine-containing mushrooms and vegetables may effectively increase testicular testosterone production. We conclude that mushrooms with a relatively high adenosine content, such as enokitake, may be useful against aging and fatigue.
Open AccessEnokitake Mushroom and Its Active Component, Adenosine, Which Restores Testosterone Production in Impaired and Fatigued Mouse Models
Several studies have reported the effects of the consumption of various mushroom species on the testes in animal experimental models. Mushrooms, including enokitake mushrooms (Flammulina velutipes), and vegetables contain adenosine may affect testosterone production. Here, we aimed to elucidate the effects of enokitake and its active component, adenosine, on testosterone production in primary cultures of testicular cells in vivo using mice models and in vitro. The administration of enokitake ethanolic extract increased testosterone production in the cisplatin-impaired mouse model. The direct effect of mushroom extracts on testicular cells was examined and liquid chromatography–mass spectrometry analysis confirmed that the mushroom- and vegetable-induced increase in testosterone production mainly involved adenosine. Additionally, the administration of enokitake extract or adenosine to wet floor fatigue model mice promoted testicular testosterone production and enhanced Leydig cell function through insulin-like peptide three level upregulation. Structurally related compounds, including cordycepin, showed lower bioactivity than adenosine. This study showed that the ingestion of adenosine-containing mushrooms and vegetables may effectively increase testicular testosterone production. We conclude that mushrooms with a relatively high adenosine content, such as enokitake, may be useful against aging and fatigue.